Forschner A - Search Results

1

Genomics of Immunotherapy-Associated Hyperprogressors-Letter.

Forschner A, Niessner H, Möller Y, Horak P, Fröhlich M, Warsow G, Stenzinger A, Fröhling S, Glimm H, Klumpp B, Garbe C, Sinnberg T. Forschner A, et al. Clin Cancer Res. 2017 Oct 15;23(20):6374-6375. doi: 10.1158/1078-0432.CCR-17-1480. Clin Cancer Res. 2017. PMID: 29030332 No abstract available.

2

Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.

Meier F, Guenova E, Clasen S, Eigentler T, Forschner A, Leiter U, Zielinski C, Knaudt B, Garbe C, Berneburg M. Meier F, et al. Among authors: forschner a. J Am Acad Dermatol. 2009 May;60(5):863-8. doi: 10.1016/j.jaad.2008.09.053. J Am Acad Dermatol. 2009. PMID: 19389529

3

Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?

Leiter U, Buettner PG, Eigentler TK, Forschner A, Meier F, Garbe C. Leiter U, et al. Among authors: forschner a. Melanoma Res. 2010 Jun;20(3):240-6. doi: 10.1097/CMR.0b013e32833716f9. Melanoma Res. 2010. PMID: 20216239

4

Melanoma staging: facts and controversies.

Forschner A, Eigentler TK, Pflugfelder A, Leiter U, Weide B, Held L, Meier F, Garbe C. Forschner A, et al. Clin Dermatol. 2010 May-Jun;28(3):275-80. doi: 10.1016/j.clindermatol.2009.06.012. Clin Dermatol. 2010. PMID: 20541679

5

Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies.

Leiter U, Eigentler TK, Forschner A, Pflugfelder A, Weide B, Held L, Meier F, Garbe C. Leiter U, et al. Among authors: forschner a. Clin Dermatol. 2010 May-Jun;28(3):311-5. doi: 10.1016/j.clindermatol.2009.10.001. Clin Dermatol. 2010. PMID: 20541684

6

Hepatic hemangioma and hemochromatosis misdiagnosed by MRI as metastatic melanoma.

Forschner A, Schmidt D, Garbe C. Forschner A, et al. J Dtsch Dermatol Ges. 2011 Oct;9(10):842-3. doi: 10.1111/j.1610-0387.2011.07759.x. Epub 2011 Jul 25. J Dtsch Dermatol Ges. 2011. PMID: 21790994 English, German. No abstract available.

7

The role of radiotherapy in the overall treatment of melanoma.

Forschner A, Heinrich V, Pflugfelder A, Meier F, Garbe C. Forschner A, et al. Clin Dermatol. 2013 May-Jun;31(3):282-9. doi: 10.1016/j.clindermatol.2012.08.009. Clin Dermatol. 2013. PMID: 23608447 Review.

8

Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.

Weide B, Faller C, Büttner P, Pflugfelder A, Leiter U, Eigentler TK, Bauer J, Forschner A, Meier F, Garbe C. Weide B, et al. Among authors: forschner a. PLoS One. 2013 Apr 29;8(4):e63137. doi: 10.1371/journal.pone.0063137. Print 2013. PLoS One. 2013. PMID: 23638183 Free PMC article.

9

Successful treatment with vemurafenib in BRAF V600K-positive cerebral melanoma metastasis.

Forschner A, Niessner H, Bauer J, Bender B, Garbe C, Meier F. Forschner A, et al. JAMA Dermatol. 2013 May;149(5):642-4. doi: 10.1001/jamadermatol.2013.372. JAMA Dermatol. 2013. PMID: 23677116 No abstract available.

10

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases.

Niessner H, Forschner A, Klumpp B, Honegger JB, Witte M, Bornemann A, Dummer R, Adam A, Bauer J, Tabatabai G, Flaherty K, Sinnberg T, Beck D, Leiter U, Mauch C, Roesch A, Weide B, Eigentler T, Schadendorf D, Garbe C, Kulms D, Quintanilla-Martinez L, Meier F. Niessner H, et al. Among authors: forschner a. Cancer Med. 2013 Feb;2(1):76-85. doi: 10.1002/cam4.50. Epub 2013 Feb 3. Cancer Med. 2013. PMID: 24133630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page